FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093751824> ?p ?o ?g. }

• W3093751824 endingPage "181" @default.
• W3093751824 startingPage "171" @default.
• W3093751824 abstract "The aim of this analysis was to evaluate the efficacy of lobeglitazone on albuminuria at 24 weeks of follow-up in patients with type 2 diabetes mellitus (T2DM) compared with pioglitazone using data from a randomized, double-blinded phase III trial. In the phase III trial, patients who were inadequately controlled with metformin received 0.5 mg of lobeglitazone or 15 mg of pioglitazone for 24 weeks. Post hoc, exploratory analysis was used to investigate mean changes from baseline in the urine albumin–creatinine ratio (UACR) between the lobeglitazone (N = 104) and pioglitazone (N = 101) treatment groups. After 24 weeks of treatment, UACR was slightly decreased in the lobeglitazone group (− 4.3 mg/g creatinine [Cr]) compared to baseline and slightly increased in the pioglitazone group (5.2 mg/g Cr), with no change in the estimated glomerular filtration rate in either group; this difference was not statistically significant (P = 0.476). The incidence of new-onset microalbuminuria (2.4%) and the progression of albuminuria by > 1 stage (2.9%) in the lobeglitazone group were lower than the respective values in the pioglitazone group (6.8 and 6.1%, respectively). Of the patients in the lobeglitazone group, 50% exhibited regression to normoalbuminuria, compared to 39.3% of the patients in the pioglitazone. In subjects in the lobeglitazone group with micro- and macroalbuminuria, UACR tended to be more decreased and HbA1c was more reduced compared to those with normoalbuminuria (P = 0.014). Lobeglitazone had a tendency to improve albuminuria in patients with T2DM and had comparable effects on albuminuria as pioglitazone which has demonstrated beneficial effects. ClinicalTrials.gov identifier, NCT01106131." @default.
• W3093751824 created "2020-10-29" @default.
• W3093751824 creator A5027444148 @default.
• W3093751824 creator A5030299195 @default.
• W3093751824 creator A5057102947 @default.
• W3093751824 creator A5069560681 @default.
• W3093751824 date "2020-10-24" @default.
• W3093751824 modified "2023-10-13" @default.
• W3093751824 title "Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus" @default.
• W3093751824 cites W1902555847 @default.
• W3093751824 cites W1966566822 @default.
• W3093751824 cites W1970733045 @default.
• W3093751824 cites W1973436528 @default.
• W3093751824 cites W1974596099 @default.
• W3093751824 cites W2007437966 @default.
• W3093751824 cites W2027790359 @default.
• W3093751824 cites W2044435399 @default.
• W3093751824 cites W2055008347 @default.
• W3093751824 cites W2057790029 @default.
• W3093751824 cites W2072070798 @default.
• W3093751824 cites W2086393043 @default.
• W3093751824 cites W2087701253 @default.
• W3093751824 cites W2096541753 @default.
• W3093751824 cites W2096556016 @default.
• W3093751824 cites W2116077357 @default.
• W3093751824 cites W2118133237 @default.
• W3093751824 cites W2121776978 @default.
• W3093751824 cites W2139074604 @default.
• W3093751824 cites W2158323596 @default.
• W3093751824 cites W2165199383 @default.
• W3093751824 cites W2555612317 @default.
• W3093751824 cites W2600729082 @default.
• W3093751824 cites W2758169111 @default.
• W3093751824 cites W2765973564 @default.
• W3093751824 cites W2769392829 @default.
• W3093751824 cites W2807299721 @default.
• W3093751824 cites W2808102136 @default.
• W3093751824 cites W2896736787 @default.
• W3093751824 cites W2904387867 @default.
• W3093751824 cites W2930550239 @default.
• W3093751824 cites W2936295302 @default.
• W3093751824 cites W2949753825 @default.
• W3093751824 cites W2967446099 @default.
• W3093751824 cites W2969746584 @default.
• W3093751824 cites W2998258269 @default.
• W3093751824 cites W3008112729 @default.
• W3093751824 cites W4240449862 @default.
• W3093751824 cites W4246340431 @default.
• W3093751824 cites W4256659255 @default.
• W3093751824 doi "https://doi.org/10.1007/s13300-020-00948-1" @default.
• W3093751824 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7843821" @default.
• W3093751824 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33099742" @default.
• W3093751824 hasPublicationYear "2020" @default.
• W3093751824 type Work @default.
• W3093751824 sameAs 3093751824 @default.
• W3093751824 citedByCount "6" @default.
• W3093751824 countsByYear W30937518242021 @default.
• W3093751824 countsByYear W30937518242022 @default.
• W3093751824 countsByYear W30937518242023 @default.
• W3093751824 crossrefType "journal-article" @default.
• W3093751824 hasAuthorship W3093751824A5027444148 @default.
• W3093751824 hasAuthorship W3093751824A5030299195 @default.
• W3093751824 hasAuthorship W3093751824A5057102947 @default.
• W3093751824 hasAuthorship W3093751824A5069560681 @default.
• W3093751824 hasBestOaLocation W30937518241 @default.
• W3093751824 hasConcept C126322002 @default.
• W3093751824 hasConcept C134018914 @default.
• W3093751824 hasConcept C2776174234 @default.
• W3093751824 hasConcept C2777180221 @default.
• W3093751824 hasConcept C2778384471 @default.
• W3093751824 hasConcept C2910068830 @default.
• W3093751824 hasConcept C555293320 @default.
• W3093751824 hasConcept C71924100 @default.
• W3093751824 hasConceptScore W3093751824C126322002 @default.
• W3093751824 hasConceptScore W3093751824C134018914 @default.
• W3093751824 hasConceptScore W3093751824C2776174234 @default.
• W3093751824 hasConceptScore W3093751824C2777180221 @default.
• W3093751824 hasConceptScore W3093751824C2778384471 @default.
• W3093751824 hasConceptScore W3093751824C2910068830 @default.
• W3093751824 hasConceptScore W3093751824C555293320 @default.
• W3093751824 hasConceptScore W3093751824C71924100 @default.
• W3093751824 hasIssue "1" @default.
• W3093751824 hasLocation W30937518241 @default.
• W3093751824 hasLocation W30937518242 @default.
• W3093751824 hasLocation W30937518243 @default.
• W3093751824 hasOpenAccess W3093751824 @default.
• W3093751824 hasPrimaryLocation W30937518241 @default.
• W3093751824 hasRelatedWork W1973522969 @default.
• W3093751824 hasRelatedWork W2003150205 @default.
• W3093751824 hasRelatedWork W2010978798 @default.
• W3093751824 hasRelatedWork W2108653508 @default.
• W3093751824 hasRelatedWork W2136047525 @default.
• W3093751824 hasRelatedWork W2755014214 @default.
• W3093751824 hasRelatedWork W2899064970 @default.
• W3093751824 hasRelatedWork W3135909533 @default.
• W3093751824 hasRelatedWork W3173349510 @default.
• W3093751824 hasRelatedWork W4210495623 @default.
• W3093751824 hasVolume "12" @default.

• next